Proscia touts study showing digital pathology software detected melanoma
The startup shared results of a prospective study showing its deep learning software detected melanoma with 93% sensitivity and 91% specificity.
Digital pathology startup Proscia lands $23M to advance software platform
Proscia and other digital-pathology firms promise to make pathologists more efficient as they analyze tissue. The need is driven by a steadily declining U.S. population of pathologists.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Proscia wraps up $8.3M Series A to expand digital pathology platform
Flybridge Capital Partners led the funding round, and Fusion Fund, Emerald Development Managers, Razor's Edge Ventures and Robin Hood Ventures also participated.
As skin cancer cases climb, Proscia plans to launch AI-powered dermatopathology product this year
Proscia has inked a deal with a dermatopathology laboratory in a move designed to support its launch of a comprehensive AI-powered digital pathology softwaredermatopathology-specific digital pathology product in the fourth quarter of 2018.
Proscia wants to bridge technology gap in cancer research
In addition to its cloud-based products for digital pathology, Proscia has released nine image analysis modules targeting prostate, breast, and skin cancer for research use only.
5 must-read stories: Digital pathology startup Proscia’s fundraise, a corporate VC investment survey
Plus, an analysis of the Providence St Joseph Health merger and what the plans are for technology, patient safety and mental health and a look at some of the largest digital health investments outside the U.S.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Proscia CEO: Digital pathology is at inflection point
Proscia CEO David West said a recent Seed round would be allocated to new jobs across product development and sales and marketing, including a director of sales position and amplify sales.
Pathology software startup using data analytics to aid cancer diagnosis has raised $1M
Proscia's platform lets users integrate multi-gigabyte digital biopsies with storage services from the likes of Dropbox, Amazon, and in-house storage systems.
Baltimore startup takes cancer fight to the cloud and combines machine learning
Proscia, a Baltimore-based startup, is looking to use machine learning and cloud-based technology to combat cancer, launching a new software platform aimed at pathologists that provides storage for multi-gigabyte digital biopsies, while simultaneously harnessing what it calls “second-opinion collaboration technology.” The cloud-based program, according to Proscia, offers “large-scale management, analytics, access and collaboration” for whole […]